-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
May 16, 2024 - orientation); may include electronic or computer-based screening KQs 4, 5: Broad-based, general settings as described … Screening to identify eligible participants must take place in broad-based, general settings as described
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
February 08, 2018 - Reaffirmation Evidence Update for this topic will be conducted using rapid synthesis procedures, as described
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
December 28, 2023 - Participant characteristics will be described with respect to factors that can contribute to variability
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
March 21, 2024 - Participant characteristics will be described with respect to factors that can contribute to variability
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review78/ovarian-cancer-screening-2012
April 15, 2012 - The USPSTF had little data on harms, but instead described the theoretical presence of important harms … studies not related to ovarian cancer, 34 studies that did not describe screening, two studies that described … no relevant outcomes, two studies that described a high-risk or special patient population, and three
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/fNXdu3HGvWE-ovsuhNeANW
April 01, 2012 - The USPSTF had little data on harms, but instead described the theoretical presence of
important harms … studies not related to ovarian cancer, 34
studies that did not describe screening, two studies that described … no relevant outcomes, two
studies that described a high-risk or special patient population, and three
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-1
December 01, 2013 - Additionally, Task Force methods were described in a special issue of the American Journal of Preventive … The nomination process and required qualifications are described on the Task Force Web site. … Each step is also described in more detail in subsequent sections of the Procedure Manual. 1.9.1 Topic … The responsibilities of the USPSTF leads are described in Appendix IV . … review, the AHRQ Medical Officer working with the Task Force leads) develops a preliminary work plan as described
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan153/ovarian-cancer-screening
March 03, 2016 - The figure is an analytic framework that depicts the two Key Questions described in the Research Plan
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources
June 22, 2025 - Task Force Resources
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Resources for Using Recommendations in Practice Prevention TaskForce App The Prevention TaskForce is an application that includes all Task Force recomm…
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-7-formulation-task-force-recommendations
June 21, 2025 - The Task Force can issue a grade of A, B, C, or D, as described in Table 4 . … The procedures for posting draft materials for public comment are described in Section 9 .
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-at-a-glance
June 22, 2025 - Task Force at a Glance
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
The U.S. Preventive Services Task Force works to improve the health of people nationwide. The U.S. Preventive Services Task Force (USPSTF or Task Force…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-obstructive-pulmonary-disease-screening
October 08, 2020 - The update for this topic will be conducted using rapid synthesis procedures, as described in Section
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
October 15, 2011 - Behaviorally based treatments were heterogeneous and specific elements were not well-described. … on 90% or more of participants with fewer than a 10–percentage point difference between groups, and described … as “single blind”), assessment and statistical methods not well described
Kastarinen et … Good
Jeffery et al, 1993 39
NR
NR
87%
No
Fair Measurement procedures not well described … fasting glucose levels higher in intervention group at baseline; measurement procedures not clearly described
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary3/chlamydia-and-gonorrhea-screening-september-2014
September 23, 2014 - Methods are further described … Studies of screening strategies were included if they adequately described the study population and comparison … Included studies used credible reference standards, adequately described the study population, defined … Three studies described additional methodological difficulties related to the reference standard 29 … Both scatterplots are further described in the evidence section for Key Question 3.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening-september-2018
August 31, 2017 - Reaffirmation Evidence Update for this topic will be conducted using rapid synthesis procedures, as described
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/methupd.pdf
July 01, 2007 - which salient
issues related to cost-effectiveness, mandates, and other implemen-
tation issues are described … The USPSTF last described its methods in 2001 (1). … This change in the
field of evidence assessment and synthesis, and the changes
described in the following
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults
January 12, 2023 - To explore variation by subpopulation, we will rely on the approach developed for USPSTF reviews described
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
January 15, 2011 - of age and included in analyses; 782 children examined in "nonscreening" city; loss to follow-up not described … amblyogenic risk factors: 45% (23/51)
Pediatric ophthalmology clinic, United States, screener not described … 300; amblyogenic risk factors: 56% (168/300)
Pediatric ophthalmology clinic, China, screener not described … 387); refractive error: 55% (211/387)
Pediatric ophthalmology clinic, United States, screener not described … 21% (21/102); organic anomaly: 13% (13/102)
Pediatric ophthalmology clinic, Germany, screener not described
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
August 24, 2021 - Two RCTs (described in 5 articles) conducted in the UK evaluated invitations to screening for diabetes … for individuals with screen-detected diabetes and 38 RCTs (described in 56 articles 16-25 , 27-35 , … This review included 5 RCTs (described in 8 articles) evaluating interventions for recently diagnosed … Four RCTs (described in 6 articles) reported on harms of interventions for screen-detected or recently … Thirty-eight RCTs (described in 58 articles) were included (eResults in the JAMA Supplement). 16-31
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary32/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-2013
May 08, 2012 - -42 , 44 , 46-50 , 53 selected (that is, not randomly assigned or not consecutive) or inadequately described … ** The sampling method was not random or consecutive or not described. †† The reference standard was … Taft et al, 2011 60 (Taft et al, 2009 61 protocol and methods described)
Mentor support vs. usual … Fair †
Taft et al, 2011 60 (Taft et al, 2009 61 protocol and methods described)
Abuse measured … None of the women described adverse effects from screening; however, 8 of 20 believed it was unremarkable